Chiesi Usa, Inc. V. Aurobindo Pharma Usa, Inc. - Cleviprex® (Clevidipine Injectable Emulsions) | Robins Kaplan LLP

Case Name: Chiesi USA, Inc. v. Aurobindo Pharma USA, Inc., Civ. No. 19-18756, 2022 WL 3703207 (D.N.J. Aug. 16, 2022) (Quraishi, J.)  Drug Product and Patent(s)-in-Suit: Cleviprex®...

Related Keywords

,Robins Kaplan ,Aurobindo Pharma United States Inc ,Chiesi United States Inc ,Patent Office ,Chiesi United States ,Pharma United States ,Chiesi Prevailed ,Original Cleviprex ,